Search

everythinglearnresearchcommunity

for

Search:↓

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

Hair follicles can help diagnose traumatic brain injury quickly and non-invasively.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

circCFAP20DC helps goat ovarian cells grow, aiding follicle development.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Injecting CHIR-99021 into goose embryos improves feather growth by changing gene activity and energy processes.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Upadacitinib may cause hair loss.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Curcumin applied to the skin can start hair growth in mice.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Alopecia areata affects quality of life more in adolescents than adults.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.